MOJOLI, MARCO ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.685
EU - Europa 204
AS - Asia 144
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 2.039
Nazione #
US - Stati Uniti d'America 1.682
CN - Cina 116
IT - Italia 54
SE - Svezia 49
FI - Finlandia 37
GB - Regno Unito 22
DE - Germania 16
UA - Ucraina 14
VN - Vietnam 14
IN - India 13
CA - Canada 3
AU - Australia 2
BG - Bulgaria 2
EU - Europa 2
FR - Francia 2
IE - Irlanda 2
BR - Brasile 1
EC - Ecuador 1
ES - Italia 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
SI - Slovenia 1
Totale 2.039
Città #
Fairfield 259
Woodbridge 212
Chandler 180
Ann Arbor 146
Houston 140
Ashburn 122
Wilmington 103
Seattle 93
Cambridge 81
Beijing 44
Medford 32
Princeton 32
San Diego 25
Des Moines 22
Nanjing 21
Padova 21
Roxbury 18
Helsinki 16
Boardman 14
Dong Ket 14
Jacksonville 12
Shenyang 7
Jinan 6
London 6
Berlin 5
Falls Church 5
Genoa 5
Hefei 5
Treviso 5
Guangzhou 4
Hebei 4
Kharkiv 3
Las Vegas 3
Nanchang 3
Norwalk 3
Tappahannock 3
Temecula 3
Borås 2
Dublin 2
Jiaxing 2
Leawood 2
Munich 2
Mussolente 2
Ogden 2
Orange 2
Paris 2
Rockville 2
San Severino Marche 2
Santo Stefano Udinese 2
Sofia 2
Tianjin 2
Washington 2
Amsterdam 1
Barcelona 1
Carol Stream 1
Chicago 1
Chorley 1
Cupertino 1
Duque de Caxias 1
Esslingen am Neckar 1
Frankfurt am Main 1
Fuzhou 1
Henderson 1
Indiana 1
Islington 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Lido di Jesolo 1
Luxembourg 1
Mahbubnagar 1
Montréal 1
Mountain View 1
New Bedfont 1
Ningbo 1
Ocean Grove 1
Quito 1
Redmond 1
Santa Clara 1
Secaucus 1
Southwark 1
Suriapet 1
Sydney 1
Taizhou 1
Venice 1
Warsaw 1
Wuhan 1
Zhengzhou 1
Totale 1.743
Nome #
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve 135
Patent foramen ovale closure and migraine time course: Clues for positive interaction 103
Blood oozing: A cause of life-threatening bleeding without overt source after transcatheter aortic valve replacement 95
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 94
Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome 94
Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies 88
Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve. 84
Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 83
Clinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413) 81
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 77
Prevalence and Impact of Atrial Fibrillation in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement An Analysis from the SOURCE XT Prospective Multicenter Registry 72
Takayasu arteritis and NYHA III/IV idiopathic cardiomiopathy: Tocilizumab proves effective and safe 72
One-Year Outcomes of a European Transcatheter Aortic Valve Implantation Cohort According to Surgical Risk 71
TCT-425 Bioresorbable vascular scaffold technology for small vessel coronary artery disease: results from the Italian multicenter RAI Registry 70
Impact of drug-eluting stent generation on patient- and stent-related adverse events of diabetic patients treated by percutaneous coronary intervention. 69
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 66
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome 66
[The PRAMI study]. 63
Mechanical interference between a closure device and the rigid stent of mitral bioprosthesis: a mechanism for closure device late dislodgement. 63
An Amulet to Say "Big is Not Enough" 60
The SAPIEN 3 valve: lights and shadows. 50
Left atrial appendage closure: beyond the artifact. 47
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis 47
Pratica clinica attuale e trend di variazione in cardiologia interventistica strutturale. Risultati di una survey multicentrica SICI-GISE in sei Regioni italiane: Toscana, Lombardia, Veneto, Emilia-Romagna, Campania e Puglia 44
Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease 41
Lo studio ABSORB III 40
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 39
[Mitral valvuloplasty in a patient with congenital kyphoscoliosis: case report and literature review] 38
Documento di posizione della Societá Italiana di Cardiologia Interventistica (SICI-GISE): terapia antitrombotica nel paziente anziano con sindrome coronarica acuta 33
[SICI-GISE Position paper: Use of Absorb BVS in clinical practice] 33
Device-related complications after Impella mechanical circulatory support implantation: an IMP-IT observational multicentre registry substudy 27
[New Technologies in coronary interventional cardiology: results from the first inter-regional survey promoted by SICI-GISE in four regions of northern Italy ("the GISE TOLOVE" area: Tuscany, Lombardy, Veneto, Emilia-Romagna)] 26
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome 12
Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials 6
Totale 2.089
Categoria #
all - tutte 7.621
article - articoli 7.334
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019129 0 0 0 0 0 0 0 0 0 29 52 48
2019/2020389 44 17 4 22 45 26 39 57 41 34 47 13
2020/2021288 5 17 7 38 7 12 16 29 30 36 54 37
2021/2022436 22 59 26 21 26 47 18 40 37 16 27 97
2022/2023353 62 43 6 54 55 33 3 19 40 3 17 18
2023/2024166 5 40 22 14 12 25 14 18 11 5 0 0
Totale 2.089